Overall rank by patents
#40,325
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 13 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
The verdict
Fundacion holds 6 US patents across 13 technology areas, rank #40,325 of 50,000 tracked assignees.
Fundacion Copec Universidad Católica has been granted 6 US utility patents between 2022 and 2025, placing Fundacion Copec Universidad Católica at rank #40,325 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.7 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Fundacion Copec Universidad Católica is one of the more focused assignees in the PatentsView dataset. By volume, Fundacion sits between Fujitsu Technology Solutions Gmbh (6 patents, rank #40,321) and Futuragene Israel Ltd. (6 patents, rank #40,329) - the closest US assignees by grant volume. The composite Innovation Score of 47.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Fundacion Copec Universidad Católica's 13.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Fundacion Copec Universidad Católica against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Fujitsu Technology Solutions GmbH
6 patents
Fukuoka Institute of Technology
6 patents
FullThrottle Technologies, LLC
6 patents
Functional Neuromodulation, Inc.
6 patents
Funkitron, Inc.
6 patents
Furious People
6 patents
Futura IP Limited
6 patents
Futuragene Israel Ltd.
6 patents
Fundacion Copec Universidad Católica
6 patents
What this shows Fundacion holds 6 patents at rank #40,325, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #40,325 in granted patent volume.
Other assignees with the most granted patents in Fundacion's primary technology class.
Fundacion's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
48 Top 18% higher than 82% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 2 | 33.3% |
| 2024 | 1 | 16.7% |
| 2025 | 3 | 50.0% |
Top 13 of 13 technology areas
Overall rank by patents
#40,325
Across all tracked assignees
47.7 out of 100
How to use this portfolio
Fundacion's 6 grants land it in the top 18% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.